AUG 10, 2026 · PHASE 3 TRIAL
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ClinicalTrials.gov
This is a Phase 3 RCT registration with no results posted; the trial is actively recruiting and designed to compare durvalumab against observation in early-stage NSCLC after surgery, but outcome data are not yet available.
Reported
Planned enrollment306
Primary outcome measureDisease-free survival (DFS) from date of ra…
Trial phasePHASE 3